How quantum computing can benefit drug discovery

In 2022, the drug discovery market was valued at $55.46 billion, and by 2032 that figure is expected to more than double to $133.11 billion. This is a huge sum of money, but after events like COVID-19, we now know that time is equally of the essence in the drug discovery industry.

With the discovery of new drugs taking up to ten years and the cost of development rising, quantum computing could have a significant impact in this area. In terms of quantum use cases, the development of broad-spectrum antiviral medications will provide immediate benefits. The pharmaceutical industry is becoming increasingly digital, with the aim of optimizing and maintaining processes throughout the development lifecycle to save time and resource costs, in line with the advent of new computing technologies.

What are the realistic quantum benefits for the life sciences?